Doctor of Optometry Program year 2025 Reported 2021–2025 Source: CMS Open Payments, 2026 publication

Caitlin Gaughan

Optometrist Shelbyville, IL Doctor of Optometry

NPI 1437757473 CMS profile 8795763

102 N Heinlein Dr, Shelbyville, IL 62565

Open in the dashboard

General payments

$2,254

69 records reported · program years 2021–2025

Research payments

$0

Paid to them · None reported · program years 2021–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Caitlin Gaughan of Shelbyville, IL is reported in the CMS Open Payments database as having received $2,254 across 69 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 80th percentile of Optometrist profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

5 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $831 24
2024 General $1,013 29
2023 General $324 11
2022 General $51 3
2021 General $35 2

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Caitlin Gaughan
  • Optometrist median
  • Middle half of Optometrist
  • National median

In program year 2025, general payments to Caitlin Gaughan were reported at $831. Among 35,373 Optometrist profiles paid that year, the median was $204 and the middle half received between $87 and $464.

Show as a table
Year Caitlin Gaughan Optometrist median Middle half National median
2019 $0 $159 $67–$371 $163
2020 $0 $72 $29–$165 $114
2021 $35 $125 $46–$292 $132
2022 $51 $162 $66–$374 $149
2023 $324 $177 $72–$406 $160
2024 $1,013 $188 $77–$427 $164
2025 $831 $204 $87–$464 $169

Breakdown

Who paid General payments · program years 2021–2025
  1. Mallinckrodt Hospital Products Inc. $436 10 payments
  2. Tarsus Pharmaceuticals, Inc. $421 11 payments
  3. Oyster Point Pharma, Inc. $369 11 payments
  4. Bausch & Lomb Americas Inc. $283 8 payments
  5. Sun Pharmaceutical Industries Inc. $221 7 payments
  6. Harrow Eye, LLC $155 3 payments
  7. Alcon Vision LLC $107 6 payments
  8. AbbVie, Inc. $98 5 payments
  9. Dompe US, Inc. $70 3 payments
  10. Allergan Inc. $35 2 payments
  11. Other $56 3 payments

Every payment, record by record

What the payments were for General payments · program years 2021–2025
  1. Food and Beverage $2,156 68 payments
  2. Education $98 1 payment
Products named General payments · program years 2021–2025
  1. ACTHAR $436 10 payments
  2. XDEMVY $404 10 payments
  3. MIEBO $241 6 payments
  4. TYRVAYA Dry Eye $222 5 payments
  5. Cequa $221 7 payments
  6. XIIDRA $218 5 payments
  7. VEVYE $155 3 payments
  8. TYRVAYA Dry eyes $146 6 payments
  9. Ryzumvi $104 4 payments
  10. LUMIGAN $84 4 payments
  11. Other $370 19 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 6 drugs

Part D claims

241

Median for Optometry: 120

Drug cost

$45,464

Median for Optometry: $8,864

Branded share of claims

13.3%

Median for Optometry: 24.3%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Restasis Cyclosporine Brand 32 $41,797
Prednisolone Acetate Generic 115 $2,901
Latanoprost Generic 56 $327
Ketorolac Tromethamine Generic 14 $301
Acyclovir Generic 13 $105
Timolol Maleate Generic 11 $33

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 27,653 Part D prescribers listed as Optometry; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 19 billing codes

Paid by Medicare

$44,969

Medicare's payments for the services billed

Medicare patients

314

Average age 74

Services billed

772

178 women, 136 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 42%
Diabetes 36%
Ischemic heart disease 29%
Depression 27%
Chronic kidney disease 24%
COPD 22%
Heart failure 16%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Payments and prescribing

First 5 of 9 products · payments 2024

Two separate records. The payments come from Open Payments and the claims from Medicare. They are set side by side because they name the same product; they do not show that a payment affected a prescription.

Products this doctor was paid in connection with in 2024, beside Medicare claims for the same product
Product Paid by Related payments Part D claims Part B services
ACTHAR
  • Mallinckrodt Hospital Products Inc. $332
$332 — —
Cequa
  • Sun Pharmaceutical Industries Inc. $156
$156 — —
MIEBO
  • Bausch & Lomb Americas Inc. $96
$96 — —
XIIDRA
  • Bausch & Lomb Americas Inc. $96
$96 — —
XDEMVY
  • Tarsus Pharmaceuticals, Inc. $93
$93 — —

A dash means Medicare published no figure for this doctor and product — fewer than 11 claims, or the product is not covered under that part — which is not the same as none. Payments are general payments only; one that names several products is split evenly between them, so an amount is payments related to the product, not money paid for it.

See all 9 in the dashboard with a free account

Records

69 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Optometrist in Illinois

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record